Condition deep dive

Treatment-Resistant Depression: When SSRIs Aren’t Enough

What treatment-resistant depression really means, why a first antidepressant may not have worked, and the evidence-based next steps when SSRIs aren’t enough.

Early morning light over a quiet Southern California canyon trail, no people

Editor's note: This page is awaiting clinical review by our Medical Director. Information is sourced from established peer-reviewed clinical literature.

Last updated:

Key takeaways

  • Treatment-resistant depression usually means at least two adequate antidepressant trials have not produced enough improvement, not that depression is untreatable.
  • Many cases that look resistant are actually 'pseudo-resistance,' where the dose was too low, the duration too short, or another condition was missed.
  • Switching antidepressants, combining or augmenting medications, and adding evidence-based therapy are standard next steps before concluding a case is truly resistant.
  • TMS is an FDA-cleared brain-stimulation treatment for depression that has not responded to medication, and esketamine and ECT are additional medical options for severe cases.
  • Structured outpatient care like PHP and IOP can intensify treatment and coordinate medication, therapy, and referrals without a hospital stay.

You did the hard part. You named what was happening, you saw a doctor, you started a medication, and you waited the weeks it was supposed to take. And then, somehow, you are still depressed. Maybe you tried a second one. Same result. It is hard to describe how discouraging that is, the quiet fear that you might be the person nothing works for.

That fear is understandable, and it is almost always wrong. When a first or second antidepressant does not do the job, it does not mean you have run out of options. It means it is time to change the approach. This guide explains what “treatment-resistant depression” actually means, why a medication may not have worked the way it should have, and what the real, evidence-based next steps look like, including the outpatient care available here in Orange County.

What does “treatment-resistant depression” actually mean?

There is no single universal definition, but the one most clinicians use is straightforward: treatment-resistant depression (often shortened to TRD) describes major depression that has not improved enough after at least two different antidepressants, each taken at an adequate dose for an adequate length of time.[3]

Two phrases in that sentence carry a lot of weight. Adequate dose means the medication was raised to a therapeutic level, not left at the low starting dose. Adequate length of time matters because antidepressants are slow; meaningful change often takes several weeks, and stopping after ten days tells you almost nothing.[1]

It also helps to separate two things that get blurred together. Response means your symptoms have improved substantially. Remission means they have largely lifted and you feel like yourself again. The goal is remission, not just feeling marginally less bad, and a lot of people labeled “resistant” are really people who got a partial response and stalled there.

The most important thing to understand is what the term is for. It is a signal to change strategy, not a diagnosis of hopelessness. It tells your care team: the standard first move did not work, so let’s do something more deliberate.

Why didn’t the first antidepressant work?

Before anyone concludes that depression is truly resistant, a careful clinician rules out the much more common explanation: the treatment was never given a fair chance. This is sometimes called pseudo-resistance, and it accounts for a surprising share of cases that look stubborn.[3]

Some of the usual reasons a medication appears to fail:

This is why a thorough reassessment is the real first step, not a third quick prescription. A clinician who actually checks whether each prior trial was adequate, and who looks for what else might be in the picture, will often find a lever that earlier care missed.

What are the next steps after SSRIs aren’t enough?

Once a fair reassessment is done, there is a well-established menu of strategies. None of them is exotic, and most people have not yet tried the ones that end up helping. Clinical guidelines generally move through these options in a stepwise way, individualized to the person.[4]

Optimize what you’re already on. Sometimes the answer is simply raising the dose of the current medication to a fully therapeutic level and giving it enough time, especially if the earlier trial was cut short.[3]

Switch medications. If one antidepressant did nothing or caused intolerable side effects, switching to a different one, sometimes from a different class, is a standard move. People who do not respond to the first medication can still respond to another.[3]

Combine or augment. Augmentation means adding a second medication that boosts the effect of the antidepressant. This is a recognized strategy for depression that has only partly responded, and it is something a psychiatric prescriber tailors to your history.[3]

Add or intensify therapy. Medication and psychotherapy are not competitors. Evidence-based talk therapy, such as cognitive behavioral therapy, treats depression directly, and combining it with medication often works better than either alone, particularly for depression that has been hard to shift.[4] If you have been doing one therapy session a week and feel stuck, increasing the intensity of treatment can be its own next step.

Treat what else is going on. If a sleep disorder, an anxiety disorder, trauma, or substance use is feeding the depression, treating that alongside the depression is often what finally lets things move.

What about TMS, ketamine, and ECT?

When several medication strategies have not been enough, there are medical treatments that work through different mechanisms than pills. These are real options, not last resorts to be ashamed of.

TMS (transcranial magnetic stimulation) is a noninvasive treatment that uses focused magnetic pulses to stimulate areas of the brain involved in mood. It is FDA-cleared for depression, does not require anesthesia, and is delivered in a series of outpatient sessions over several weeks.[2] It is one of the more common next steps when antidepressants have not produced enough improvement.

Esketamine (Spravato) is an FDA-approved nasal-spray medication specifically for treatment-resistant depression, given under medical supervision in a certified setting and used together with an oral antidepressant.[1] Because of how it is administered and monitored, it is prescribed and overseen by specialized providers.

ECT (electroconvulsive therapy) has a difficult reputation that does not match modern practice. Done today under anesthesia, it remains one of the most effective treatments for severe or life-threatening depression, and it is an important option when rapid response is needed.[2]

Whether any of these fits you is a clinical decision made with a psychiatric provider who knows your full history. The point worth holding onto is that the list of effective treatments for depression is long, and most people who feel out of options have only worked through the first part of it.

Where does outpatient care fit in?

A lot of people with depression that has not responded to a medication or two do not need a hospital. What they need is more than a fifteen-minute med check and a weekly therapy hour can provide. That gap, more intensive than standard outpatient care but without an inpatient stay, is exactly where structured outpatient programs live.

At Manifest Behavioral Health, that care is delivered through outpatient levels: a partial hospitalization program (PHP), an intensive outpatient program (IOP), a virtual IOP, and ongoing aftercare. These programs can do several things at once that are hard to coordinate when your care is scattered across separate offices. A psychiatric provider can review your medication history, see whether prior trials were truly adequate, and adjust the plan. Therapy happens several times a week instead of once. And if depression is wrapped up with anxiety, trauma, or substance use, those are treated by the same team rather than handed off.

Two things are worth being clear about. First, Manifest is an outpatient provider; it does not offer medical detox or residential or inpatient care. If an assessment shows you need medically supervised withdrawal or a higher level of care first, the team helps coordinate that referral so the right step happens safely. Second, the correct level of care is a decision made with you, based on your symptoms and your safety, not a label assigned in advance. Some people step down into IOP after a more intensive period; others start at IOP and add support as they go.

If you want to understand how this compares with other options, our guide on signs your weekly therapy isn’t enough walks through when it is time to step up the intensity of care.

How to take the next step

If you have tried an antidepressant or two and you are still struggling, the most useful thing you can do is get a real reassessment rather than assume the story is over. A good evaluation asks the questions earlier care may have skipped: Was each medication given a fair trial? Is something else driving this? What strategies have you genuinely not tried yet?

To talk through outpatient options for depression that has not responded to medication, you can contact Manifest Behavioral Health in Laguna Hills, CA, at (949) 735-5705. We serve adults across Orange County.

If you are in crisis, please do not wait. Call or text 988 for the Suicide and Crisis Lifeline, or call 911 if there is immediate danger. For free, confidential help with mental health and substance use, SAMHSA’s national helpline is 1-800-662-4357, available 24/7.


This article is for educational purposes and is not a substitute for individualized medical or mental health advice. Decisions about starting, stopping, switching, or combining medication, or about treatments like TMS, esketamine, or ECT, should be made with a qualified clinician who knows your history.

Frequently asked questions

  • How many antidepressants do I have to try before it's called treatment-resistant?
    Most clinicians use the threshold of at least two different antidepressants, each taken at an adequate dose for an adequate length of time, without enough improvement. Before applying that label, a good evaluation checks whether each trial was actually adequate, since stopping early or staying on too low a dose is a common reason a medication looks like it failed when it never had a fair trial.
  • Does treatment-resistant depression mean nothing will work?
    No. The term describes how depression has responded to specific medications so far, not a permanent verdict. Many people who did not respond to one or two antidepressants improve after switching medications, adding a second medication, intensifying therapy, or trying a treatment like TMS. The goal of the label is to prompt a change in strategy, not to end the search.
  • What is TMS, and is it right for me?
    Transcranial magnetic stimulation (TMS) is a noninvasive, FDA-cleared treatment that uses magnetic pulses to stimulate brain regions involved in mood regulation. It is typically considered when depression has not responded to medication, does not require anesthesia, and is done in a series of outpatient sessions. Whether it fits your situation is a decision to make with a psychiatric provider who knows your history.
  • When is depression a medical emergency?
    If you or someone you love is thinking about suicide, having thoughts of self-harm, or in immediate danger, call or text 988 (Suicide and Crisis Lifeline) or call 911 right away. You do not need to wait for an appointment. For free, confidential mental health and substance use support, SAMHSA's national helpline is 1-800-662-4357, available 24/7.

References

  1. [1] National Institute of Mental Health (NIMH). "Depression." NIMH Publication, 2024. Source
  2. [2] National Institute of Mental Health (NIMH). "Brain Stimulation Therapies." 2024. Source
  3. [3] Voineskos D, Daskalakis ZJ, Blumberger DM. "Management of Treatment-Resistant Depression: Challenges and Strategies." Neuropsychiatric Disease and Treatment. 2020;16:221-234 (PubMed/PMC). Source
  4. [4] National Institute for Health and Care Excellence (NICE). "Depression in adults: treatment and management." NG222, 2022. Source